Galapagos制药 GLPG 深 沪
已收盘 09-19 16:00:00 美东时间
30.44
+0.160
+0.53%
华盛通- 最 高31.0623
- 今 开30.10
- 成交量 17.52万股
- 最 低 29.84
- 昨 收 30.28
- 总市值 20.06亿
- 52周最高 42.455
- 市盈率 静 8.76
- 换手率 0.27%
- 52周最低 24.16
- 委 比 -42.78%
- 总股本 6589.71万
- 历史最高 274.03
- 量 比 1.24
- 振 幅 4.04%
- 历史最低 13.023
- 每 手 1
- 风险率 5.11%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多扭亏为盈无望，投资人等不下去了
近日，由知名生物技术投资者Oleg Nodelman管理的生物技术对冲基金Ecor1 Capital已将其在比利时制药商Galapagos NV的持股比例增至...
08-28 09:20
Galapagos up 10% as major shareholder intends to talk about strategy
Galapagos (NASDAQ:GLPG) shares are up ~10% in Monday trading after a large shareholder in the company said it believes the company is undervalued and wants to talk to management and the board about pe...
08-27 00:41
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
U.S. stocks were mostly higher, with the Dow Jones index gaining around 150 poi...
08-26 21:59
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Shares of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) rose sharply in today's pre-...
08-26 17:58
Galapagos gains after FDA nod for lymphoma trial
Galapagos (NASDAQ:GLPG) shares traded higher in Europe on Friday after the U.S. Food and Drug Administration (FDA) greenlighted a Phase 1/2 trial for its CAR-T cell therapy, GLPG5101, in non-Hodgkin l...
08-23 18:53
Galapagos CAR-T Pipeline Challenges Prompt Sell Rating
Jason Gerberry, an analyst from Bank of America Securities, reiterated the Sell...
08-04 22:23
Galapagos pauses enrollment in Phase 1/2 study for GLPG5301
Galapagos (NASDAQ:GLPG) said it has paused enrollment in a Phase 1/2 study of its therapy candidate GLPG5301 after a case of Parkinsonism was observed. The Belgium-based biotech company said in its e...
08-03 03:05
Galapagos downgraded at Raymond James on lack of business development
Reversing modest gains recorded in the previous session following the company’s Q2 results, Galapagos (NASDAQ:GLPG) shares turned lower on Friday as Raymond James downgraded the Belgian biotech, citin...
08-03 01:58
Galapagos (GLPG) Receives a Buy from TD Cowen
In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating o...
08-02 23:56
Galapagos GAAP EPS of €1.51, revenue of €140.3M
Galapagos press release (NASDAQ:GLPG): 1H GAAP EPS of €1.51. Revenue of €140.3M (+18.3% Y/Y). More on Galapagos Galapagos NV (GLPG) Q1 2024 Earnings Call Transcript Adaptimmune, Galapagos to collabora...
08-02 04:51
